CAYENNE WEB DEVELOPMENT LIMITED

Company number 04502369 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Score: F (Critical Condition)

This business is displaying severe symptoms of financial distress. It is technically insolvent, meaning its liabilities far exceed its assets, and it is suffering from acute cash flow anemia. The company is currently kept alive on financial life support, relying entirely on director funding to stave off terminal failure.

Key Vital Signs

  • Solvency (Net Assets/Liabilities): -£27,998
    • Interpretation: The patient’s "body mass" is deeply negative. A healthy business has assets that exceed its liabilities, providing a buffer against shocks. Cayenne Web Development’s liabilities outweigh its assets by nearly £28,000, indicating severe balance sheet insolvency.
  • Cash Reserves: £1,661
    • Interpretation: The financial blood pressure is dangerously low. Cash is the oxygen of any business, and reserves have hemorrhaged from a healthy £23,589 in 2019 to a dangerously thin £1,661 in 2024. This leaves the business with virtually no liquidity to cover everyday expenses without external intervention.
  • Current Ratio (Current Assets vs. Current Liabilities): 0.05
    • Interpretation: For every £1 of short-term debt the business owes, it has only 5p in assets to pay it. This is a critical symptom of an entity unable to meet its immediate obligations without emergency intervention.
  • Director's Loan (Creditor): £28,825
    • Interpretation: This is the financial life support system. The vast majority of the company's liabilities (approximately 97%) are money owed to its own directors. While this means external creditors are minimal, it highlights that the business cannot sustain itself through its own operational heartbeat (revenue).

Diagnosis

The patient is suffering from a chronic, long-term deteriorating condition that has accelerated over the last five years.

Looking at the medical history, the business was healthy in 2019, boasting positive net assets of £13,155 and a strong cash pulse of £23,589. However, an underlying illness took hold in 2020, plunging the net assets into negative equity and draining the cash reserves. By 2022, the accumulated losses required heavy transfusions from the directors, resulting in a directors' loan of over £31,000.

While there is a very slight stabilization between 2023 and 2024—the directors' loan decreased slightly from £31,325 to £28,825, and net liabilities remained relatively flat at around £28,000—the overall constitution remains critical. The business is surviving, not thriving. It is entirely dependent on the willingness and financial capacity of its directors to continue funding its working capital shortfall. The lack of debtors (money owed by clients) and minimal trade creditors suggest the business may be operating at a very low volume of activity, further evidenced by having only one employee.

Recommendations

To give this business a chance at recovery, immediate and aggressive treatment is required:

  1. Secure the Life Support (Formalize the Director Loan): The directors must ensure the loan agreement is properly documented and subordinated (ranked behind other debts) if seeking external funding. This protects the company from sudden demands for repayment that would immediately kill the business.
  2. Stop the Bleeding (Urgent Cash Flow Generation): The business needs an emergency transfusion of revenue. Focus exclusively on high-margin, quick-turnaround IT consultancy projects that generate immediate cash. Halt any activities that tie up cash without a rapid return.
  3. Financial Surgery (Debt-to-Equity Conversion): The directors should consider converting a significant portion of their £28,825 loan into share capital. While this doesn't bring in new cash, it cleans up the balance sheet, turning a suffocating liability into permanent equity, which makes the business look healthier to any future lenders or clients who perform credit checks.
  4. Insolvency Risk Assessment: The directors must regularly monitor whether there is a reasonable prospect of the company paying its debts as they fall due. If the operational heartbeat does not return, continuing to trade while insolvent can lead to accusations of wrongful trading. If recovery is impossible, the directors should consider a voluntary strike-off before the debts grow larger.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 9 September 2026